Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 23 December 2008, doi:10.1136/bmj.a3044
Cite this as: BMJ 2008;337:a3044
Daniel Grossman, senior associate , assistant clinical professor1,2
1 Ibis Reproductive Health, San Francisco, California, USA, 2 Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco
DGrossman@ibisreproductivehealth.org
Two areas in London are piloting over the counter oral contraceptives. Daniel Grossman argues that the policy should be widely adopted but Sarah Jarvis (doi:10.1136/bmj.a3056) believes it is the wrong approach to reducing unplanned pregnancy
| The first 150 words of the full text of this article appear below. |
Oral contraceptives are the most widely used hormonal method of contraception globally and the most commonly used reversible method in less developed countries other than China.1 The pill is highly effective and with perfect use has a failure rate of 0.3% in the first year.2 But in practice failure is much higher—closer to 8% or 9%.3 In most countries, women must have a doctors prescription to obtain oral contraceptives, although many developing countries do not enforce this and pills are effectively available over the counter.
Data from the United States suggest that, for at least some women, the prescription requirement represents a barrier to both initiation and continuation of hormonal contraceptives. A US national survey of women in 2004 reported that 41% of women not currently using contraception said they would start using the pill, patch, or vaginal ring if it were available directly in a pharmacy.4 Another study found
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses